Literature DB >> 10227471

Experimental infection of sheep with bovine herpesvirus type-5 (BHV-5): acute and latent infection.

A M Silva1, R Weiblen, L F Irigoyen, P M Roehe, H J Sur, F A Osorio, E F Flores.   

Abstract

We demonstrated that sheep are susceptible to acute and latent infection by bovine herpesvirus type-5 (BHV-5). Lambs inoculated intranasally with two South American BHV-5 isolates replicated the virus with titers up to 10(7.1) TCID50/ml for up to 15 days and showed mild signs of rhinitis. Four lambs in contact with the inoculated animals acquired the infection and excreted virus for up to seven days. One lamb developed progressive signs of neurological disease and was euthanized in extremis. Clinical signs consisted of tremors of the face, bruxism, ptyalism, incoordination, lateral flexion of the neck and head, circling, walking backwards, recumbency and paddling. The virus was detected in the anterior and posterior cerebrum, dorso- and ventro-lateral cortex, cerebellum, pons, midbrain and olfactory bulb. Viral nucleic acids were demonstrated in neurons and astrocytes of the anterior and ventro-lateral cortex by in situ hybridization. Histological changes consisting of non-suppurative meningitis, perivascular mononuclear cuffing, focal gliosis, neuronal necrosis and intranuclear inclusions were observed in the anterior cerebrum, ventro-lateral cortex and midbrain. Dexamethasone treatment at Day 50 pi resulted in reactivation of the latent infection and virus shedding in 13/16 (81%) of the lambs. Together with previous reports of BHV-5 antibodies in sheep, these findings show that sheep are fully susceptible to BHV-5 suggesting that infection by BHV-5 in sheep may occur naturally.

Entities:  

Mesh:

Year:  1999        PMID: 10227471     DOI: 10.1016/s0378-1135(98)00305-8

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  6 in total

1.  Susceptibility of mice to bovine herpesvirus type 5 infection in the central nervous system.

Authors:  L P Mesquita; R C Costa; M M Fusuma; F R P Bruhn; E Mori; E M Pituco; C M C Mori; R Weiblen; P C Maiorka
Journal:  Vet Res Commun       Date:  2017-09-23       Impact factor: 2.459

2.  Characterization of BoHV-5 field strains circulation and report of transient specific subtype of bovine herpesvirus 5 in Argentina.

Authors:  Silvina S Maidana; María F Ladelfa; Sandra E Pérez; Patricia M Lomónaco; María P Del Médico Zajac; Anselmo Odeón; Javier Blanco Viera; Gustavo Combessies; Norberto Fondevila; María Palacios; Julien Thiry; Benoît Muylkens; Etienne Thiry; Sonia A Romera
Journal:  BMC Vet Res       Date:  2011-02-07       Impact factor: 2.741

3.  Immunohistochemical approach to the pathogenesis of clinical cases of bovine Herpesvirus type 5 infections.

Authors:  Tereza C Cardoso; Heitor F Ferrari; Andrea F Garcia; Livia C Bregano; Alexandre L Andrade; Adriana Hc Nogueira
Journal:  Diagn Pathol       Date:  2010-09-10       Impact factor: 2.644

4.  Improved antigenic methods for differential diagnosis of bovine, caprine, and cervine alphaherpesviruses related to bovine herpesvirus 1.

Authors:  Véronique Keuser; Frédéric Schynts; Bruno Detry; Alfred Collard; Béatrice Robert; Alain Vanderplasschen; Paul-Pierre Pastoret; Etienne Thiry
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

5.  Distribution of bovine herpesvirus type 5 DNA in the central nervous systems of latently, experimentally infected calves.

Authors:  Fernanda Silveira Flôres Vogel; Luizinho Caron; Eduardo Furtado Flores; Rudi Weiblen; Evandro Reinoldo Winkelmann; Sandra Vanderli Mayer; Reginaldo Gaspar Bastos
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

6.  Co-housing of Rift Valley Fever Virus Infected Lambs with Immunocompetent or Immunosuppressed Lambs Does Not Result in Virus Transmission.

Authors:  Paul J Wichgers Schreur; Lucien van Keulen; Jet Kant; Nadia Oreshkova; Rob J M Moormann; Jeroen Kortekaas
Journal:  Front Microbiol       Date:  2016-03-07       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.